Business
Abivax Biotech Stock Surge
French biotech company Abivax saw its stock price surge 31% after releasing positive data on its experimental medicine for bowel disease. This could have significant implications for the treatment of inflammatory bowel diseases.
Coverage timeline — 1 article
CNBC
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
2026-06-30 08:05 UTC